CellBion Co., Ltd. (KOSDAQ:308430)
South Korea flag South Korea · Delayed Price · Currency is KRW
37,300
-400 (-1.06%)
At close: Apr 29, 2026

CellBion Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9452,2901,4711,763916.88
Revenue Growth (YoY)
-15.05%55.64%-16.54%92.27%-32.61%
Cost of Revenue
1,8621,3271,1581,5591,044
Gross Profit
83.39963.28313.52203.57-126.94
Selling, General & Admin
3,2352,7111,9682,4432,017
Research & Development
4,9565,2703,3892,9762,340
Other Operating Expenses
136.31118.08-87.8666.61
Operating Expenses
8,3288,1005,3575,5074,423
Operating Income
-8,245-7,137-5,043-5,303-4,550
Interest Expense
-137.03-535.88-140.18-352.51-276.8
Interest & Investment Income
813.93405.331,542124.236.07
Currency Exchange Gain (Loss)
1.48---0.130.01
Other Non Operating Income (Expenses)
-7.37-0.29.06-1,01413.34
EBT Excluding Unusual Items
-7,574-7,267-3,633-6,546-4,778
Gain (Loss) on Sale of Assets
-0.031.29---0
Other Unusual Items
---164.1-
Pretax Income
-7,574-7,266-3,633-6,382-4,778
Net Income
-7,574-7,266-3,633-6,382-4,778
Net Income to Common
-7,574-7,266-3,633-6,382-4,778
Shares Outstanding (Basic)
131010109
Shares Outstanding (Diluted)
131010109
Shares Change (YoY)
26.24%2.27%2.28%10.36%1.48%
EPS (Basic)
-591.00-715.78-366.00-657.64-543.34
EPS (Diluted)
-591.00-716.00-366.00-658.00-543.34
Free Cash Flow
-7,018-4,904-4,240-5,074-3,572
Free Cash Flow Per Share
-547.60-483.08-427.15-522.88-406.23
Gross Margin
4.29%42.07%21.31%11.55%-13.84%
Operating Margin
-423.87%-311.67%-342.79%-300.83%-496.28%
Profit Margin
-389.38%-317.32%-246.92%-362.02%-521.08%
Free Cash Flow Margin
-360.79%-214.16%-288.18%-287.84%-389.58%
EBITDA
-7,995-6,922-4,842-4,944-3,900
EBITDA Margin
----280.44%-
D&A For EBITDA
249.4215.01201.75359.53650.52
EBIT
-8,245-7,137-5,043-5,303-4,550
Advertising Expenses
9.915.27-7.577.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.